A Digital Measure of Eye Movements During Reading Sensitively Captures Oculomotor and Speech Dysfunction, Early Changes, and Disease Progression in Ataxias
Annals of Neurology · 2025
DOI: 10.1002/ana.78039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, 2025. Verfasst von Brandon Oubre und 10 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Reading, Ataxia, Eye Movements, Ocular Motility Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Objective
Sensitive behavioral measures are needed for clinical trials in ataxias and other neurodegenerative diseases. We hypothesized that quantitative analysis of eye movements during a natural multi‐component task (passage reading) could produce a measure capable of capturing subclinical signs and disease progression.
Methods
Binocular gaze sampled at 1000 hertz (Hz) was collected from 102 individuals with ataxia (including 36 spinocerebellar ataxias, 12 Friedreich's ataxia, and 5 multiple system atrophy) and 70 healthy controls. Longitudinal data were available for 26 participants with ataxia in the ongoing Neurobooth natural history study. The Reading Eye Abnormality Digital (READ) score was developed by training a regression model to aggregate saccade and fixation kinematics.
Results
Mean displacement of fixations, the number and frequency of saccades, and the proportion of regressive saccades were related to oculomotor dysfunction, speech dysfunction, and overall ataxia severity. The READ score was reliable (intraclass correlation coefficient [ICC] = 0.96, p < 0.001) and correlated with Brief Ataxia Rating Scale (BARS) total score ( r = 0.82, p < 0.001), oculomotor ( r = 0.52, p < 0.001), and speech ( r = 0.73, p < 0.001) subscores, and patient reports of function including patient‐reported outcome measures (PROM)‐Ataxia ( r = 0.51, p < 0.001) and the Dysarthria Impact Scale (DIS; r = 0.53, p < 0.001). The READ score detected subclinical oculomotor (area under the curve [AUC] = 0.69, p = 0.02) and speech signs (AUC = 0.72, p < 0.001) and disease progression ( d = 0.36, p = 0.03). The BARS total did not reach statistical significance in capturing progression between study visits in this cohort ( d = 0.27, p = 0.08).
Interpretation
Digital measures of eye movements are a promising approach for sensitively measuring ataxia in clinical trials (including early‐stage disease) and may have utility in other neurodegenerative diseases affecting speech or ocular control. ANN NEUROL 2025
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Harvard Medical School, Boston, MA.
- Department of Neurology, Massachusetts General Hospital, Boston, MA.
- Department of Neurology, Ataxia Center, Massachusetts General Hospital, Boston, MA.
ORCID-Profile: Brandon Oubre, Christopher D Stephen
Förderung
- NINDS NIH HHS
Zitieren
APA
Oubre, B., Yang, F., Luddy, A. C., Manohar, R., Soja, N. N., Stephen, C. D., Schmahmann, J. D., Kulkarni, D., White, L., Patel, S., & Gupta, A. S. (2025). A Digital Measure of Eye Movements During Reading Sensitively Captures Oculomotor and Speech Dysfunction, Early Changes, and Disease Progression in Ataxias. Annals of Neurology. https://doi.org/10.1002/ana.78039
Vancouver
Oubre B, Yang F, Luddy AC, Manohar R, Soja NN, Stephen CD, et al. A Digital Measure of Eye Movements During Reading Sensitively Captures Oculomotor and Speech Dysfunction, Early Changes, and Disease Progression in Ataxias. Annals of Neurology. 2025. doi:10.1002/ana.78039
BibTeX
@article{Oubre2025,
author = {Oubre, Brandon and Yang, Faye and Luddy, Anna C and Manohar, Rohin and Soja, Nancy N and Stephen, Christopher D and Schmahmann, Jeremy D and Kulkarni, Divya and White, Lawrence and Patel, Siddharth and Gupta, Anoopum S},
title = {A Digital Measure of Eye Movements During Reading Sensitively Captures Oculomotor and Speech Dysfunction, Early Changes, and Disease Progression in Ataxias},
journal = {Annals of Neurology},
year = {2025},
doi = {10.1002/ana.78039}
}
EUVIMED